INR 8.93
(-0.11%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 537.34 Million INR | 1069.57% |
2022 | 45.94 Million INR | 344.72% |
2021 | 10.33 Million INR | -83.18% |
2020 | 61.4 Million INR | -29.88% |
2019 | 87.57 Million INR | 298.9% |
2018 | 21.95 Million INR | 3.02% |
2017 | 21.31 Million INR | 213000.0% |
2016 | 10 Thousand INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 537.34 Million INR | 1069.57% |
2023 Q3 | 537.34 Million INR | -9.24% |
2023 Q2 | 592.03 Million INR | 0.0% |
2023 Q1 | 592.03 Million INR | 1188.59% |
2023 Q4 | 537.34 Million INR | 0.0% |
2022 Q4 | 45.94 Million INR | 0.0% |
2022 Q3 | 45.94 Million INR | 0.0% |
2022 Q1 | - INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 727.95 Million INR | 26.184% |
Checkpoint Trends Limited | 4 Million INR | -13309.279% |
Everest Organics Limited | 1.8 Billion INR | 70.293% |
GUJARAT INJECT (KERALA) LTD. | 1.47 Million INR | -36429.3% |
NEXUS SURGICAL AND MEDICARE LI | 12.39 Million INR | -4233.453% |
Rajnish Wellness Limited | 222.75 Million INR | -141.225% |
Rama Vision Limited | 291.78 Million INR | -84.156% |
Vivo Bio Tech Limited | 827.33 Million INR | 35.051% |